Truist Financial opens the week with analyst focus, shares in review

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 20:51.

Truist Financial (US89832Q1094) starts Tuesday with a clear analyst backdrop. Truist Securities has recently adjusted several U.S. names, including Incyte and Robinhood, according to market reports and analyst notes.Truist Securities note on Incyte

Analyst tone stays active

One dated update from Truist Securities lifted Incyte to a $105 price target from $103 and kept a Hold rating, as reported by Moomoo on June 23, 2026. The same day, Investing.com reported a Truist Buy reiteration on Robinhood after a June volume update.Investing.com on the Robinhood update

For Truist Financial stock, that matters because the firm sits in the same U.S. banking universe that watches rates, credit quality and trading activity closely. MarketBeat also tracks the New York-listed shares under ticker TRU and shows the stock around $65.86 in intraday trade, with a 2.22 percent gain at the cited snapshot.MarketBeat TRU quote page

Tuesday’s consensus lens

Tuesday is a natural day for consensus work, and Truist sits in the large-cap U.S. banking peer group with names such as JPMorgan Chase, Bank of America and Wells Fargo. That peer set gives investors a direct read on how regional and money-center banks trade against rate expectations and loan growth.

For Truist, the analyst frame is useful because the bank’s own stock often tracks broader financial-sector sentiment rather than one single headline. The New York listing gives the shares a clear U.S. market anchor, with market data monitored through the NYSE and quote services cited above.

What Truist sells

Truist Financial is a diversified U.S. bank built around retail banking, commercial lending, wealth management and capital markets services. Its core franchise centers on deposit gathering and credit intermediation, with fee income adding a second earnings stream.

Where the shares trade

The Truist Financial shares (US89832Q1094) trade on the NYSE in U.S. dollars. MarketBeat cited the shares at $65.86 at 03:34 PM Eastern on 2026-06-23.

Disclaimer: This article is for information only and does not constitute investment advice.